US Worldmeds

Zimhi

Manufacturer:

US Worldmeds

Zimhi HCPCS:

J2311

HCPCS Code Descriptor:

Injection, naloxone hydrochloride (zimhi), 1 mg

Category:

J Code

Zimhi NDCs:

78670-0140-02

Primary Type:

Opiod abuse

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

78670-0140-02

About Zimhi:

Zimhi is an Opiod abuse drug manufactured by US Worldmeds and administered via the Injection route of administration. The J Code: J2311 is aligned to the drug Zimhi.

ACCESS PRICING AND MORE BY REGISTERING

J2311 Added Date:

January 1, 2023

J2311 Effective Date:

January 1, 2023

J2311 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Zimhi billing and coding information.
Zimhi patient assistance information can be found through US Worldmeds at the URL: https://zimhi.com/patients-and-caregivers/prescription-savings/
Zimhi prescribing information can be found at the link below:
Information regarding Zimhi’s side effects can be found at MedlinePlus